Regional survey of tuberculosis risk assessment in rheumatology outpatients commencing anti-TNF-α treatment in relation to British Thoracic Society guidelines

Author： John H   Buckley C   Koh L   Obrenovic K   Erb N   Rowe IF  

Publisher： Royal College Of Physicians

ISSN： 1470-2118

Source： Clinical Medicine, Vol.9, Iss.3, 2009-06, pp. : 225-230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

According to The British Society for Rheumatology guidelines, 5.6% of outpatients with rheumatoid arthritis (RA) in the West Midlands, UK, are eligible for anti-tumour necrosis factor (TNF) monoclonal antibody therapy

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 422, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Anti-TNF-α therapy in ankylosing spondylitis

By Wendling Daniel   Toussirot Eric  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 7, 2004-07 ,pp. : 1497-1507

Informa Healthcare

Access to resources Recommend Favorite

Anti-TNF-α polyclonal antibodies fab in severe sepsis

By  

Inpharma, Vol. 1, Iss. 1557, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Anti-TNF-α therapies in chronic obstructive pulmonary diseases

By Antoniu Sabina A   Mihaltan Florin   Ulmeanu Ruxandra  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 8, 2008-08 ,pp. : 1203-1211

Informa Healthcare

Access to resources Recommend Favorite

Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF-α therapy

By Barygina V.V.  

Redox Report, Vol. 18, Iss. 3, 2013-05 ,pp. : 100-106

Maney Publishing

Access to resources Recommend Favorite